By reducing the activity of ACE2, SARS-CoV-2 may cause a significant advantage of angiotensin 2 over angiotensin (1-7), which, in the light of the data presented above, may adversely affect many functions of the human body, for example lung function, causing acute respiratory failure (ARDS). Here, AGT is linked to acute respiratory distress syndrome.